Mitofilin: Key factor in diabetic cardiomyopathy?

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 292-293

  Gorr, Matthew W ^a   Wold, Loren E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MITOFILIN; UNCLASSIFIED DRUG; MITOCHONDRIAL PROTEIN; MUSCLE PROTEIN;

APOPTOSIS; BREATHING RATE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; EDITORIAL; ELECTRON TRANSPORT; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FUNCTION; HEART VENTRICLE FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; ISCHEMIA; LIPID PEROXIDATION; MITOCHONDRION; NONHUMAN; PHOTODYNAMICS; PRIORITY JOURNAL; PROTEOMICS; SYSTOLIC DYSFUNCTION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; HEART; HEART MITOCHONDRION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HEART; HUMANS; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MUSCLE PROTEINS;

EID: 84938973194     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.11.028     Document Type: Editorial

References (19)

1. Diabetes Association American Statistics about diabetes (accessed November 13, 2013). http://www.diabetes.org/diabetes-basics/statistics.
2. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013, 36(Suppl. 1):S67-74. 10.2337/dc13-S067.
3. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34. 10.1016/0002-9149(74)90089-7.
4. Bertoni A.G., Tsai A., Kasper E.K., Brancati F.L. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 2003, 26:2791-2795. 10.2337/diacare.26.10.2791.
5. De Simone G., Devereux R.B., Chinali M., Lee E.T., Galloway J.M., Barac A., et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010, 28:353-360. 10.1097/HJH.0b013e3283331169.
6. Thrainsdottir I.S., Aspelund T., Thorgeirsson G., Gudnason V., Hardarson T., Malmberg K., et al. The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care 2005, 28:612-616. 10.2337/diacare.28.3.612.
7. Sommer J.R.J.E. Ultrastructure of cardiac muscle. Handbook of physiology, Bethesda, MD 1979, 113-186. R. Berne (Ed.).
8. Anderson E.J., Kypson A.P., Rodriguez E., Anderson C.A., Lehr E.J., Neufer P.D. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 2009, 54:1891-1898. 10.1016/j.jacc.2009.07.031.
9. Baseler W.A., Dabkowski E.R., Williamson C.L., Croston T.L., Thapa D., Powell M.J., et al. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol 2011, 300:R186-R200. 10.1152/ajpregu.00423.2010.
10. Dabkowski E.R., Williamson C.L., Bukowski V.C., Chapman R.S., Leonard S.S., Peer C.J., et al. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol 2009, 296:H359-H369. 10.1152/ajpheart.00467.2008.
11. Shen X., Zheng S., Thongboonkerd V., Xu M., Pierce W.M., Klein J.B., et al. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab 2004, 287:E896-E905. 10.1152/ajpendo.00047.2004.
12. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., Abel E.D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005, 112:2686-2695. 10.1161/CIRCULATIONAHA.105.554360.
13. Boudina S., Bugger H., Sena S., O'Neill B.T., Zaha V.G., Ilkun O., et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009, 119:1272-1283. 10.1161/CIRCULATIONAHA.108.792101.
14. John G.B., Shang Y., Li L., Renken C., Mannella C.A., Selker J.M.L., et al. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell 2005, 16:1543-1554. 10.1091/mbc.E04-08-0697.
15. Thapa Dharendra, Nichols Cody E., Lewis Sara E., Shepherd Danielle L., Jagannathan Rajaganapathi, Croston Tara L., et al. Transgenic overexpression of mitofilin attenuates diabetes mellitus-associated cardiac and mitochondria dysfunction. J Mol Cell Cardiol 2014, 79:212-223. 10.1016/j.yjmcc.2014.11.008.
16. Adhihetty P.J., Ljubicic V., Menzies K.J., Hood D.A. Differential susceptibility of subsarcolemmal and intermyofibrillar mitochondria to apoptotic stimuli. Am J Physiol Cell Physiol 2005, 289:C994-C1001. 10.1152/ajpcell.00031.2005.
17. Judge S., Jang Y.M., Smith A., Hagen T., Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005, 19:419-421. 10.1096/fj.04-2622fje.
18. Magi B., Ettorre A., Liberatori S., Bini L., Andreassi M., Frosali S., et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ 2004, 11:842-852. 10.1038/sj.cdd.4401427.
19. Von der Malsburg K., Müller J.M., Bohnert M., Oeljeklaus S., Kwiatkowska P., Becker T., et al. Dual role of mitofilin in mitochondrial membrane organization and protein biogenesis. Dev Cell 2011, 21:694-707. 10.1016/j.devcel.2011.08.026.